Navigation Links
‘Benign’ MS May Not Be So Benin

People who have multiple sclerosis (MS) for 10 years and have few of the disabling symptoms of the disease are often told they// have “benign MS” and that their symptoms will likely not ever occur to the same extent as other people with MS. A new study shows that unfortunately this may not be correct.

After 20 years, the disease had progressed in nearly half of those whose MS was benign at 10 years, according to the study.

The study of 169 people whose MS was benign after 10 years found that after 20 years the disease had progressed in 21 percent to the extent that they needed a cane to walk. Most of the patients had the relapsing-remitting form of the disease, where symptoms come and go. But after 20 years, about 20 percent of the people had developed the secondary-progressive form of the disease, where the disease steadily progresses.

“We need to be careful what we tell people, and not give them false hope that their symptoms may never get worse,” said lead study author Ana-Luiza Sayao, MD, of the University of British Columbia in Vancouver, Canada.

“We hoped to identify risk factors that make people more likely to progress in the disease after 10 years of a benign course, but we did not find that gender, the symptoms when the disease began, or age when the disease began were associated with either disease progression or remaining benign,” said study author Virginia Devonshire, MD, of the University of British Columbia in Vancouver, Canada. “More research needs to be done to identify criteria to determine which people will remain with mild disability over the long term.”

Source-NewswiseBR>SRM
'"/>




Page: 1

Related medicine news :

1. Accuracy of Some Natural Family Planning Methods Questioned .
2. Natural formula for protection against vision loss
3. Naturally Occurring Hormone Can Lead To Miscarriage
4. Treating Leukemia With Natural Cells
5. Natural Sulfur Can Treat Pain From Osteoarthritis
6. Chronic Post-Traumatic Stress Disorder (PTSD) Risk In Young Natural Disaster Survivors
7. Tsunami Unplugged: Natural Disasters Favor the Under-privileged
8. ‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scientit
9. An After-Dinner Nap Is A Natural Thing, Scientists Proved
10. The Most Natural Thing in the World
11. Natural Approach to Immune Regulation May Help Transplant Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: May Not Benin
TAG: May Not Benin


(Date:12/2/2008)...c. 2 VirtualScopics, Inc...tative imaging for clinical,trials, today announc...,compared to $14.7 million at the same time a year...lculates backlog as the amount remaining to be,re...ration of the studies,included within the backlog...
(Date:12/2/2008)...ew Report Finds Many Cite Prevention, Shedding, or...2 A New Center for Stat...how states are balancing retiree health care plans...ree Health Care in the American States examines h... retiree health care benefits to central human res...
(Date:12/2/2008)... Patients treated with radiation prior to surger...of cancer recurrence and better overall survival r...The report examined a treatment called neoadjuvant... limit the spread of cancer, before surgery to rem...motherapy and/or radiation. , Neoadjuvant thera...
(Date:12/2/2008)...A new report from the Institute of Medicine propos...workloads to decrease the chances of fatigue-relat...ronment for these doctors in training. The report...rk hours from the maximum average of 80 per week s...al Education (ACGME) in 2003, but rather reduces t...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
...ican Journal of Preventive Medicine says that ther...sease. These conclusions were arrived at by resea...ealth at the Centers for Disease Control and Preve...pondents who took part in the 1999-2002 Behavioral...
...evealed that a version of the Viagra pill meant fo...nction market is much larger when compared to that...o develop a pill for that, according to Ellis. The...an has to be factored in for developing the pill, ...
...ents with psychiatric disorders. The number of pat... by 12% in the past 4 years. This shows us that ...ties. According to the Australian Institute of He... number of patients attending to specialized psych...
...of Camembert cheese with the microorganism E.coli,...d from supply due to potential risk of food poison...ning notice against consumption of this cheese. A...etes a bacterial toxin named verocytotoxins has be...
Other Medicine News:Health News:Community hospitals inundated with Psychiatric care cases (12%) 2
(Date:12/1/2008)...ire/ -- S*BIO Pte Ltd today announced the initiati...nt and orally-active JAK2 inhibitor, in leading me...ic idiopathic myelofibrosis (CIMF). , , Th...erability of SB1518 in patients with CIMF and is e...art of the study will assess the safety profile an...
(Date:12/1/2008)...tasia Treated With ENB-0040 at Children,s Hospital...NTREAL, Dec. 1 Enobia Pharma, an e...ping novel therapeutics for serious bone disorders... its clinical program for hypophosphatasia was dos...rapy (ERT) with ENB-0040 for the treatment of this...
(Date:12/1/2008)...the best policy , , ROCHESTER, Minn., Dec....o Clinic finds the use of the drug therapy etanerc...n acute inflammation of the liver caused by excess...dy are published in the December issue of Gastroe... , VIDEO ALERT: Additional audio and video re...
(Date:12/1/2008)...cember 1 Following a,Re...to procure an MVA-based,third generation smallpo...anada, on behalf of the Canadian Department of Nat... Nordic for the delivery of IMVAMUNE(R). , ... as part of the,country,s bio-preparedness progra...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Tumor inhibiting protein could be effective in treating leukemia 4038 1Tumor inhibiting protein could be effective in treating leukemia 4038 2BIO key 28R 29 Issues Open Letter to Shareholders 4036 1BIO key 28R 29 Issues Open Letter to Shareholders 4036 2BIO key 28R 29 Issues Open Letter to Shareholders 4036 3BIO key 28R 29 Issues Open Letter to Shareholders 4036 4BIO key 28R 29 Issues Open Letter to Shareholders 4036 5Incorrectly cleaved protein leads to schizophrenia 6541 1Incorrectly cleaved protein leads to schizophrenia 6541 2Vitalize 28TM 29 Receives Top Multivitamin Rating 23988 1Vitalize 28TM 29 Receives Top Multivitamin Rating 23988 2
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors.
The opaque outer circle will white-out even the darkest iris, making your pupil the only spot of black in a sea of white.
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background.
Medpor Sphere Inserter. The Inserter is provided as a value added item to Medpor Orbital Implants.
Medicine Products: